Literature DB >> 15254712

Identification and characterization of human TMEM25 and mouse Tmem25 genes in silico.

Masuko Katoh1, Masaru Katoh.   

Abstract

Immunoglobulin superfamily members are implicated in immune responses, growth factor signaling, and cell adhesion. IGSF4 (IGSF4A), homologous to IGSF4B, IGSF4C, IGSF4D, PVR, PVRL1, PVRL2, PVRL3 and PVRL4, is down-regulated in lung cancer. IGSF11, homologous to CXADR (CAR), ESAM and ASAM, is up-regulated in the intestinal-type gastric cancer. Here, we identified and characterized a novel member of the immunoglobulin superfamily, TMEM25, by using bioinformatics. BC042896 and AY358919 cDNAs were derived from human TMEM25 gene, while AK002841 cDNA was derived from mouse Tmem25 gene. TMEM25 isoform 1 (BC042896), consisting of exons 1-9, encoded a 366-aa transmembrane protein. TMEM25 isoform 2 (AY358919), consisting of exons 1-4 and 6-9, encoded a 322-aa secreted protein. Human TMEM25 gene was found to encode transmembrane-type as well as secreted-type proteins due to alternative splicing of exon-skipping type. TMEM25 mRNA was expressed in brain, including cerebellar cortex and hippocampus, as well as in neuroblastoma, brain tumors, and gastric cancer. Human TMEM25 isoform 1 showed 91.0% total-amino-acid identity with mouse Tmem25. TMEM25 was identified as a member of immunoglobulin superfamily, because codon 42-112 of TMEM25 was the C-2 type immunoglobulin domain homologous to Hemicentin (Fibulin-6, FIBL6), Titin (TTN), Sialoadhesin (SN) and Nephrin (NEPHS1). Human TMEM25 gene was located at the 11q23.3 oncogenomic recombination hotspot around the MLL amplicon and the neuroblastoma deleted region. TMEM25 is a target of pharmacogenomics in the field of oncology and regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254712

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  TMEM25 modulates neuronal excitability and NMDA receptor subunit NR2B degradation.

Authors:  Haiqing Zhang; Xin Tian; Xi Lu; Demei Xu; Yi Guo; Zhifang Dong; Yun Li; Yuanlin Ma; Chengzhi Chen; Yong Yang; Min Yang; Yi Yang; Feng Liu; Ruijiao Zhou; Miaoqing He; Fei Xiao; Xuefeng Wang
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

2.  Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders.

Authors:  Xi Rao; Kriti S Thapa; Andy B Chen; Hai Lin; Hongyu Gao; Jill L Reiter; Katherine A Hargreaves; Joseph Ipe; Dongbing Lai; Xiaoling Xuei; Yue Wang; Hongmei Gu; Manav Kapoor; Sean P Farris; Jay Tischfield; Tatiana Foroud; Alison M Goate; Todd C Skaar; R Dayne Mayfield; Howard J Edenberg; Yunlong Liu
Journal:  Mol Psychiatry       Date:  2019-09-02       Impact factor: 15.992

3.  Whole Exome Sequencing in Two Southeast Asian Families With Atypical Femur Fractures.

Authors:  Wei Zhou; Hanh H Nguyen; Denise M van de Laarschot; Tet Sen Howe; Joyce S B Koh; Frances Milat; Jeroen G J van Rooij; Joost A M Verlouw; Bram C J van der Eerden; Mark Stevenson; Rajesh V Thakker; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2022-07-03

4.  Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.

Authors:  Weili Jia; Qianyun Yao; Yanfang Wang; Zhenzhen Mao; Tianchen Zhang; Jianhui Li; Ye Nie; Xinjun Lei; Wen Shi; Wenjie Song
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

5.  Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma.

Authors:  Isabelle Atkins; Ben Kinnersley; Quinn T Ostrom; Karim Labreche; Dora Il'yasova; Georgina N Armstrong; Jeanette E Eckel-Passow; Minouk J Schoemaker; Markus M Nöthen; Jill S Barnholtz-Sloan; Anthony J Swerdlow; Matthias Simon; Preetha Rajaraman; Stephen J Chanock; Joellen Shildkraut; Jonine L Bernstein; Per Hoffmann; Karl-Heinz Jöckel; Rose K Lai; Elizabeth B Claus; Sara H Olson; Christoffer Johansen; Margaret R Wrensch; Beatrice Melin; Robert B Jenkins; Marc Sanson; Melissa L Bondy; Richard S Houlston
Journal:  Cancer Res       Date:  2019-02-01       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.